Australia markets closed

GSK plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
20.95-0.76 (-3.50%)
At close: 03:29PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close21.71
Open20.53
Bid0.00 x 0
Ask0.00 x 0
Day's range20.53 - 20.95
52-week range16.65 - 21.71
Volume996
Avg. volume1,598
Market cap85.32B
Beta (5Y monthly)0.26
PE ratio (TTM)13.69
EPS (TTM)1.53
Earnings dateN/A
Forward dividend & yield0.81 (3.87%)
Ex-dividend date22 Feb 2024
1y target estN/A
  • Bloomberg

    Pfizer Sells £3 Billion of Shares in Sensodyne Maker Haleon

    (Bloomberg) -- Pfizer Inc. has sold over £3 billion ($3.8 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce its 32% stake. Most Read from BloombergApple Is in Talks to Let Google Gemini Power iPhone AI FeaturesTrump Rules Out Vivek Ramaswamy as Running Mate as He Eyes New TeamNvidia Unveils Successor to Its All-Conquering AI ProcessorMusk Says His Ketamine Prescription Is in Investors’ Best InterestsEvergrande’s Alleged $78 Billion

  • Bloomberg

    Pfizer Plans to Sell About £2 Billion of Shares in Haleon

    (Bloomberg) -- Pfizer Inc. plans to sell about £2 billion ($2.5 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce its 32% stake. Most Read from BloombergApple Is in Talks to Let Google Gemini Power iPhone AI FeaturesPutin Warns Russia Won’t Stop After Predictable Election WinSaudi Wealth Fund Is in Talks to Acquire National AirlineTop Solar Firm Longi Plans Thousands of Job Cuts on GlutChina’s Growth Bump May Dent Urgency for More

  • Business Wire

    Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer

    PHILADELPHIA, March 16, 2024--RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer